News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Yakup Ergün: Nivolumab/Relatlimab or Nivolumab/Ipilimumab in TNBC
Photo of Yakup Ergün from obdh.com.tr
Sep 20, 2024, 08:16

Yakup Ergün: Nivolumab/Relatlimab or Nivolumab/Ipilimumab in TNBC

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X:

“Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in TNBC with high TILs: BELLINI trial

Stage I-II, node negative, TILs ≥50%, 30 patients

  • pCR
  • Nivo+IPI – 33%
  • Nivo+RELA – 47%

Remarkable efficacy of chemotherapy-free immunotherapy for immunogenic TNBC”

Yakup Ergün

Source: Yakup Ergün/X

 

 

BELLINI trial cancer immunogenic TNBC neoadjuvant immunotherapy nivolumab/ipilimumab nivolumab/relatlimab OncoDaily Oncology Yakup Ergün
Special Coverage
Celebrities
Jan 16, 2025, 17:18
Bob Uecker Dies at 90 from Small-Cell Lung Cancer
Insight
Jan 16, 2025, 16:45
The 2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
Insight
Jan 16, 2025, 16:28
ACS CAN Report: High Costs Block Critical Follow-Up Tests for Breast Cancer
Blog
Jan 16, 2025, 16:20
Genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC - ASGO Education
Science
Jan 16, 2025, 16:10
Neoadjuvant therapy in patients with left-sided resectable pancreatic cancer
Blog
Jan 16, 2025, 16:05
David Wakeling: Alice’s Arc’s new research grant to some of the best minds in US paediatric cancer research
Science
Jan 16, 2025, 16:03
Estela Rodriguez: Updated analysis of CM816
Blog
Jan 16, 2025, 16:01
Elizabeth Ugwoma Awo-Ejeh: The Power of Showing Up - Closing the 10-Day Challenge
Career
Jan 16, 2025, 15:57
Elene Mariamidze: I finally got into the 2025 IASLC Academy
Insight
Jan 16, 2025, 15:50
The Gynaecology Course at the 17th BGICC
Insight
Jan 16, 2025, 15:49
Elvina Almuradova: Delighted to continue serving as a ESO Ambassador for Turkey
Blog
Jan 16, 2025, 15:46
Roupen Odabashian: Why do I see more young patients with cancer?